SEI Investments’s Xtant Medical Holdings XTNT Stock Holding History

SEI Investments’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.8K	Buy	+24,760	New	+$15.2K	﹤0.01%	3224

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SEI Investments's XTNT Position: Q1 2026 in Review

SEI Investments opened a new position in Xtant Medical Holdings (XTNT) in Q1 2026: 24,760 shares worth $13.8K. The stake represents ﹤0.01% of the portfolio and ranks #3224 among its holdings.

34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

SEI Investments held 24,760 shares of Xtant Medical Holdings worth $13.8K as of Q1 2026.
Xtant Medical Holdings was a new SEI Investments position in Q1 2026.
Xtant Medical Holdings made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3224 holding.
34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.